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Activity-based training with the Myosuit: 
a safety and feasibility study across diverse gait 
disorders
Florian Leander Haufe1* , Kai Schmidt1,2, Jaime Enrique Duarte2, Peter Wolf1, Robert Riener1,3  
and Michele Xiloyannis1
Abstract 
Background: Physical activity is a recommended part of treatment for numerous neurological and neuromuscular 
disorders. Yet, many individuals with limited mobility are not able to meet the recommended activity levels. Light-
weight, wearable robots like the Myosuit promise to facilitate functional ambulation and thereby physical activity. 
However, there is limited evidence of the safety and feasibility of training with such devices.
Methods: Twelve participants with diverse motor disorders and the ability to walk for at least 10 m were enrolled 
in this uncontrolled case series study. The study protocol included five training sessions with a net training time 
of 45 min each. Primary outcomes were the feasibility of engaging in training with the Myosuit, the occurrence of 
adverse events, and participant retention. As secondary outcomes, we analyzed the walking speed using the 10-m 
Walk Test (10MWT) and for three participants, walking endurance using the 2-min Walk Tests.
Results: Eight out of 12 participants completed the entire study protocol. Three participants withdrew from the 
study or were excluded for reasons unrelated to the study. One participant withdrew because of an unsafe feeling 
when walking with the Myosuit. No adverse events occurred during the study period for any of the participants and 
all scheduled trainings were completed. For five out of the eight participants that completed the full study, the walk-
ing speed when using the Myosuit was higher than to their baseline walking speed.
Conclusions: Activity-based training with the Myosuit appears to be safe, feasible, and well-tolerated by individuals 
with diverse motor disorders.
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Exomuscle
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Background
Physical inactivity has been identified as the fourth 
leading risk factor for global mortality, only surpassed 
by hypertension, tobacco use, and hyperglycemia. To 
contain the risks associated with physical inactivity, the 
World Health Organization recommends that all adults 
engage in moderate intensity physical activity for at least 
150 min each week [1].
Physical activity is also a recommended part of 
treatment for stroke patients [2], and for patients with 
incomplete spinal cord injury (SCI) [3], inherited 
neuropathies such Charcot–Marie–Tooth disease [4], 
heart failure [5], or chronic obstructive pulmonary 
disease [6]. These wide-ranging recommendations reflect 
the consistent association between increased physical 
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In spite of the evident health benefits of physical 
activity, a large proportion of elderly individuals and 
individuals with limited mobility do not meet the 
recommended dose of physical activity in their daily lives 
[10]. In many of these cases, neurological, neuromuscular, 
or cardiovascular deficits prevent individuals from 
reaching moderate intensity levels during exercise. 
In some cases, they prohibit any voluntary exercise 
altogether.
To address this problem, various technological 
solutions like full-leg, rigid exoskeletons have been 
developed to assist overground mobility (e.g. [11–14].). 
The safety and feasibility of gait training with mobile 
exoskeletons has been evaluated in several longitudinal 
training studies for individuals with spinal cord injury 
[15–17] and hemiparesis following stroke [18, 19]. Rigid 
exoskeletons largely substitute the ambulatory function 
of severely affected or completely paralyzed individuals 
and enable them to walk. Electric motors are used to 
provide large assistive torques to the users’ leg joints 
via rigid linkages. This allows exoskeletons to support 
the majority of the users’ weight and advance the users’ 
legs without a major voluntary contribution from the leg 
muscles.
The typically large masses of mobile rigid exoskeletons 
increase limb inertia and thereby hinder walking at 
higher speeds. The highest walking speed achieved in 
previous training studies [15–19] was 0.67  m/s, while 
most speeds were as low as 0.1 m/s to 0.4 m/s. This is well 
below the speeds required to support individuals with 
residual mobility during moderate intensity exercise.
To assist this more capable section of the population, 
more lightweight wearable robots (also known as 
“exosuits”, “exomuscles” or “dermoskeletons”) have been 
proposed [20–24]. Unlike exoskeletons that act on all 
leg joints, these devices allow for—and require—the 
active participation of the user, and can (partially) assist 
walking over a larger range of speeds [20, 25]. Thereby, 
such wearable robots can provide assistance as needed 
for functional ambulation [25] while simultaneously 
modulating the cardiovascular load of their users 
according to exercise recommendations. For example, 
a soft robotic exosuit unilaterally acting on one ankle 
joint was shown to reduce the energy expenditure and 
interlimb asymmetry of individuals with hemiparesis 
following a stroke during walking at 0.5 to 1.3 m/s [20]. 
In previous work from our group, we demonstrated 
that a soft wearable robot actively supporting hip and 
knee extension, the Myosuit, enabled an individual 
with incomplete SCI to walk substantially faster when 
assisted [25]. More recently, we showed that this 
functional improvement also translates to an increase 
in exercise intensity and a momentary reduction of the 
energetic cost of transport [26]. In larger longitudinal 
studies, training with wearable robots acting on the 
hip joint was shown to result in an intrinsic reduction 
of the cost of transport for elderly individuals [23] and 
individuals following stroke [24].
Further work [27–29] has primarily focused on the 
functional effects of robotic movement assistance. A 
lightweight wearable robot that assists knee flexion and 
extension reduced momentary movement performance, 
but elicited larger intrinsic improvements after 2 weeks 
of exercise training than when training without the 
device in users with multiple sclerosis [27]. In larger 
randomized controlled trials with individuals post-
stroke, training with a robotic knee brace was shown 
to result in only modest functional benefits that were 
comparable to the control group [28], while training 
with a hip exoskeleton resulted in more pronounced 
functional benefits [29].
While it is hard to synthesize common trends out of 
the limited studies available, it appears that the most 
pronounced improvements were so far achieved with 
devices that targeted a very specific motor deficit (e.g. 
ankle assistance [20] or hip assistance [24, 29] improved 
hemiparetic gait for individuals after stroke). Other 
findings with devices that bear promise to work for more 
diverse gait disorders were based on single-participant 
observations [22, 25, 26], and it remains unclear to what 
extend these results generalize to larger populations.
There is limited evidence of how a single wearable 
robot could effectively assist individuals with diverse 
neuromuscular and neurological gait disorders during 
exercise training. Such a wider applicability would be 
highly desirable considering that in everyday clinical life, 
patients present with a wide array of different conditions 
and functional deficits [30].
We believe that the Myosuit is a promising device to 
assist the training of individuals with diverse gait disor-
ders. The Myosuit assists walking in essential functions 
[31] by supporting the user’s bodyweight from weight 
acceptance through mid-stance and assisting swing ini-
tiation from terminal stance into early swing (see Fig. 1b). 
By working in parallel with the user’s hip and knee exten-
sor muscles and exploiting natural synergies [32], the 
Myosuit supports the muscles with the largest contribu-
tion to bodyweight support in that phase of walking [33]. 
Training with the Myosuit can extend beyond step train-
ing and into areas of balance, strength, and coordination.
This support is packaged in a system that weighs only 
5.5  kg which means little interference with the user’s 
movements [25]. The assistance level can be adjusted for 
each leg allowing for a high degree of personalization to 
the user’s training needs.
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In this study, we investigated the safety and feasibil-
ity of assisting individuals across diverse neurological 
and neuromuscular gait disorders while training with 
the Myosuit. The study was designed as a longitudinal, 
uncontrolled case series with functional assessments 
(10MWT, for some participants 2minWT) in each ses-
sion. The results from these functional assessments 
were primarily interpreted with respect to partici-
pant familiarization and tolerance to using the Myo-
suit. With the aim of maximizing the diversity among 
individual cases, we included participants that had a 
confirmed diagnosis of any pathology that leads to a 
weakness of the legs and were able to walk for at least 
10  m without the assistance of a person (see Table  1). 
Internal tests prior to this study showed that these 
general inclusion criteria better captured the ability to 
use the Myosuit than for example individual muscle 
strength scores.
The present study is meant to inform the feasibility 
and design of a future randomized controlled trial in 
which the efficacy of Myosuit-assisted training can be 
systematically compared to conventional therapy.
Methods
Study participants and recruitment
Twelve participants were screened and recruited for 
this study (see Table  2) through referral from clinicians 
or word of mouth between September 2019 and 
February 2020 and participated in at least the initial 
training session after giving their informed consent. 
All participants were naïve, first-time users of wearable 
robotic technology. The study design and protocol were 
approved by the institutional review board of ETH Zurich 
(EK 2018-N-31) and classified as a non-interventional 
trial, thereby excluding it from trial registration.
Wearable robot
We used the Myosuit (MyoSwiss AG, Zurich, 
Switzerland) for this study.
The Myosuit is a wearable robot designed to assist 
across activities of daily life such as walking, standing, 
sitting transfers, or stair negotiation. It is comprised of 
a backpack-style motor driver unit, a textile upper body 
vest with a waist belt, and two polymer knee orthoses 
(see Fig.  1a). Two adjustable polymer springs frontally 
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Fig. 1 a Schematic drawing of the Myosuit. On each leg, an actuated cable is routed across the hip and knee joints and driven by electric motors 
contained in a backpack unit. b The motors tension the cables to apply forces assisting hip and knee extension against gravity during parts of the 
stance phase of walking. From terminal stance into swing, the springs assist hip flexion. c Exemplary picture of training with the Myosuit
Table 1 Study eligibility criteria
Inclusion criteria Exclusion criteria
Age between 18 and 80 years
Body mass index of 30 kg/m2 or below
Body height of 1.90 m or below
Written informed consent
Able to comply with all protocol requirements
Confirmed diagnosis of a pathology that leads to a weakness of the legs










































Table 2 Study participant characteristics
T Thoracic spinal segment, L Lumbar spinal segment, m. musculus n. nervus
ID Symbol Sex Age (years) Body 
height 
(cm)
Body mass (kg) Case description Time since event/diag Self-reported 
walking level






P1 f 43 164 48 Muscular atrophy due to 
Charcot–Marie–Tooth 
disease
n/a Outdoor < 1 km None 1.16 3′973
- f Multiple sclerosis
Withdrew due to home clinic 
therapist advising against 
continuation
0.92
- m 55 178 74 Grade II brain tumor, right-
sided hemiparesis. Excluded 
due to study-unrelated 
hospitalization
0.64
- m 27 175 69 Limb-girdle muscle dystrophy
Withdrew because of unsafe 
feeling with the Myosuit
0.96
P2 m 67 168 79 Motor-incomplete spinal cord 
injury at T7 (left) and T8 
(right) (AIS D)
10.5 years Outdoor < 1 km Bilateral crutches or canes, 
wheelchair
0.53 3′891
P3 m 32 185 104 Sensorimotor-complete spinal 
cord injury at L4
(AIS A, detailed scores see 
Additional file 1: Fig. S3), 
cauda equina syndrome
8 years Outdoor > 1 km Bilateral crutches or canes, 
powered scooter
0.64 12′031
P4 m 54 186 67 Syringomyelia at T5 (AIS 
D, detailed scores see 
Additional file 1: Fig. S4)
18 years Outdoor < 1 km Bilateral crutches or canes 0.18 1′990
P5 m 72 164 72 Post-stroke left-sided 
hemiparesis
6 years Outdoor < 1 km Unilateral walking cane 0.45 5′637
– m Muscle dystrophy
Excluded due to time 
constraints
0.68
P6 m 63 177 73 Post-stroke right-sided 
hemiparesis
16 years Outdoor > 1 km None 1.70 9′011
P7 f 67 160 65 Spinal tumor at L1, L2, 
left-sided lower extremity 
paresis
24 years Only indoor Bilateral crutches or canes, 
wheelchair
0.38 349
P8 f 49 181 91 Surgical removal of m. psoas 
major, n. femoralis and 
n. obturatorius following 
muscle sarcoma
4.5 months Outdoor > 1 km Unilateral walking cane 0.92 4′288
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cross the hip joints to passively assist hip flexion. Two 
ultra-high-molecular-weight polyethylene cables are 
actively driven by two electric motors housed inside the 
backpack driver unit. The two cables are routed in tex-
tile guides across the user’s lower back and buttocks, one 
on each leg. They laterally cross the thighs and enter the 
knee orthoses in which they are frontally routed across 
the knee joints and anchored on the shin segments of the 
orthoses. This mechanical setup results in an underactu-
ated coupling of hip and knee extension.
The electric motors are powered by an exchangeable 
Li-Ion battery, rendering the Myosuit completely unteth-
ered and autonomous. The motors generate linear forces 
of up to 230 N during normal walking and of up to 400 N 
during sit-to-stand transfers. This results in moments 
of 8 to 15 Nm across the knee joint and of 12 to 22 Nm 
with respect to the hip joint, assuming a mechanical 
transmission efficiency of 40% and anthropometric data 
from [34]. During walking, the cables were tensioned in 
parts of the stance phase (approx. between 10 and 40% 
of stride) to assist hip and knee extension against gravity 
(see Fig. 1b). The duration of assistance was individually 
adjusted for each leg and participant to maximize sup-
port but avoid undesirable locking towards the end of 
stance. During the assistive phase, the robotic controller 
modulated forces relative to the momentary knee angle 
(see Fig. 1b). Gait events and joint angles were estimated 
from inertial measurement unit data. The magnitude of 
the assistance was individually selected for each leg and 
each participant and kept constant for all assessments in 
the study (see Table  3). During other exercise modules, 
constant forces or force patterns designed to assist sit-to-
stand transitions were applied. Myosuit assistance can be 
adjusted over 6 levels (0 to 5). The chosen setting acts as 
global scaling factor on the assistive forces provided by 
the suit, e.g. if the setting is 3, then 3/5 or 60% of the max-
imally available assistance during walking (230 N) is pro-
vided. Prototypes of the present device were described in 
more detail in previous work [21, 25].
Study protocol
General
All trainings were accompanied by a certified 
physiotherapist and a technical expert familiar with the 
Myosuit. Participants completed a total of five training 
sessions. Each session started with a 10-m Walk Test 
(10MWT), was then followed by a physiotherapy session 
of at least 45  min, and ended with a second 10MWT. 
In session 0, both 10MWTs were performed without 
the Myosuit. Three participants performed a 2-min 
Walk Test (2minWT) instead of the second 10MWT. 
The training sessions were set to last 45  min because 
this is the recommended and reimbursed length of an 
extended physiotherapy session in Switzerland [35]. 
After each session, the physiotherapists performed a 
brief examination of the body sites most susceptible to 
skin irritations, except for those that are very difficult to 
access (e.g. lower gluteal region, rear thighs).
During 10MWTs, participants were instructed to 
“walk as fast as safely possible from the start to the fin-
ish line”. The middle 6 m were considered for the calcu-
lation of walking speed. During 2minWTs, participants 
were instructed to “cover as much distance as possible 
within the next 2 min, always turning when reaching the 
ends of the (15.24 m (50 ft) long, straight [36]) walkway”. 
Habitual compensatory strategies and the use of addi-
tional personal assistive devices such as crutches, canes, 
or orthoses were intentionally allowed for to render the 
study more representative of typical exercise training, 
but kept consistent throughout the study (see Table  3). 
Table 3 Myosuit assistance given  as  supporting force per  unit of  bodyweight (N/kg) and  additional aids used 
by participants during 10MWTs and 2minWTs
ID Symbol Myosuit assistance left leg (N/
kg)
Myosuit assistance right leg 
(N/kg)
Additional assistive devices
P1 1.0 1.9 –
P2 2.3 2.3 Bilateral crutches
P3 1.8 1.8 Bilateral crutches
Bilateral ankle–foot orthoses
P4 2.1 2.1 Bilateral crutches
Ankle–foot orthosis on right foot
P5 1.9 0.0 Cane on right side
Ankle–foot orthosis on left foot
P6 1.9 1.9 –
P7 1.4 0 Bilateral crutches
P8 1.5 0 –
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Training sessions were scheduled on a weekly basis, the 
participants’ schedules permitting.
Training session 0
During the initial training session, therapists confirmed 
that the participants were able to stand up from a chair 
and walk for at least 10  m without assistance from a 
person. The participants’ baseline walking speed was 
calculated as the mean of two 10MWTs; one done at the 
beginning and one at the end of training. For participants 
who performed a 2minWT in lieu of the second 10MWT, 
the result from the first 10MWT was taken as-is. An 
exercise program for training was designed based on the 
individual participant’s functional status.
Following the assessments, participants were 
introduced to the Myosuit and assisted to don the device. 
They then engaged in the previously selected exercises 
for approximately 45  min of net training time before 
taking off the Myosuit. For three arbitrarily selected 
participants, a 2minWT without the Myosuit was 
performed at the end of training session 0.
Interview after session 0
Two days after training session 0, participants were 
contacted by a physiotherapist and questioned in an 
unstructured, open-ended manner about their subjective 
experience with the Myosuit and about any adverse 
or positive effects of the training. Participants were 
asked if they experienced any pain during or after the 
training, if they felt fatigued after the training, and if they 
experienced delayed onset muscle soreness (DOMS) the 
day after training. Excessive fatigue and excessive DOMS 
were considered as adverse events. Other frequently 
discussed items included the regeneration after training, 
or any perceived influence on activities of daily living.
Training session 1–4
At the beginning and end of each subsequent training 
session (1 to 4), a 10MWT with assistance from the 
Myosuit was performed. The participants engaged in 
the exercise program designed in training session 0 for 
45 min. For those participants who performed a 2minWT 
without the Myosuit in training session 0, a 2minWT 
with assistance from the Myosuit was incorporated into 
the exercise program in lieu of the second 10MWT.
Exercise modules
In addition to overground and treadmill walking 
training, various exercises targeting balance, strength, 
and combined functional tasks were included in the 
training program. Balance was practiced in different 
stances (one legged, parallel, step) and in combination 
with head and upper body rotations. To train leg muscle 
strength, the exercises included repeated unilateral 
eccentric and concentric hip extensor training, abduction 
movements, and bilateral eccentric and concentric knee 
extension exercises, similar to squats. Depending on their 
individual skill level, participants performed repeated sit-
to-stand and stand-to-sit transitions and walked up and 
down stairs to combine these skills in relevant activities 
of daily life.
Outcome measures
As primary outcomes we considered the feasibility of 
engaging in an exercise program with the Myosuit, the 
occurrence of adverse events, and participant retention. 
Feasibility was defined as the ability of the participants 
to complete their individual exercise program in all 
five training sessions, the 10MWTs and, if applicable, 
2minWTs with the Myosuit.
As secondary outcome measures we considered 
the change in 10MWT walking speed and—for 
some participants—the change in 2minWT walking 
distance. We consider positive changes in these metrics 
indicative of familiarization and tolerance to using the 
Myosuit. In contrast, negative changes indicate a lack of 
familiarization and intolerance to using the Myosuit.
Additional measurements were taken for monitoring 
purposes and as exploration into potential confounders 
to the primary and secondary outcome measures. During 
all 10MWTs and 2minWTs, bidirectional audiovisual 
recordings were made. The participants’ heart rates 
were measured with wrist-worn fitness watches (Charge 
3, Fitbit Inc., San Francisco, USA) and their perceived 
exertion was assessed using the Borg Scale [37]. The 
participants were asked to wear the fitness watches 
between training session during their daily activities to 
obtain a mean step count estimate representative of their 
activity level. The watches were linked to anonymized 
accounts to safeguard the participants’ privacy.
Many of these outcomes serve as exploratory variables 
to inform a future larger randomized controlled trial in 
which the efficacy of Myosuit-assisted training will be 
systematically compared to conventional therapy.
Results
Participant retention
Eight out of 12 enrolled participants reached the study 
endpoint and completed all five training sessions 
(see Table  2) for a total of 45 training sessions. One 
participant withdrew from the study because he did not 
feel safe with the Myosuit.
Three other participants withdrew or were excluded 
for reasons unrelated to the study. For one participant, 
the treating therapist at the home clinic advised against 
study continuation for undisclosed reasons. One 
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participant could not attend subsequent sessions due to 
time constraints. For one participant, a routine check-up, 
unrelated to our study, revealed progressive growth 
of a pre-existing brain tumor that required immediate 
in-hospital treatment and precluded further participation 
in the study.
Feasibility and safety
All eight participants who reached the study endpoint 
were able to complete their exercise program and 
the scheduled assessments in all training sessions 
(10MWT and in some cases, 2minWT). The remaining 
four participants were able to complete all scheduled 
assessments up until the point of withdrawal or exclusion 
from the study. No adverse events occurred during study 
sessions. Participant P4 reported moderate pain radiating 
along the sciatic nerve right after the training session, a 
condition that he reports to regularly experience also 
outside the study. All other participant experienced 
no pain after the training. No participant experienced 
excessive fatigue after the training. Five out of eight 
participants reported moderate DOMS on the days 
following the training sessions. The physiotherapists’ 
examination of skin contact sites after the trainings did 
not reveal any skin damage or bruises.
Self-reported effects of training
All participants reported normal regeneration after 
training with the Myosuit. Some participants felt 
they slept better than usual the night after training, 
and some reported to generally feel more active and 
perform everyday movements more consciously. Other 
participants felt no effects following the training.
Walking speed (10MWT)
From training session 2 onwards, five participants 
improved their walking speed (see Fig. 2). For three par-
ticipants, the walking speeds were as fast as or slower 
than at baseline without the Myosuit.
The median walking speed was as fast as at baseline 
without the Myosuit during the first 10MWTs with the 
Myosuit (0% change, see Fig. 2). By training session 4, the 
median walking speed during 10MWTs was 22% faster 
than at baseline. Absolute changes in 10MWT walking 
speed in session 4 compared to baseline ranged from 
− 0.1 to 0.82 m/s.
Walking endurance (2minWT)
Three participants completed additional 2minWT dur-
ing their trainings. For two out of these three participants 
their walking distance in the first 2minWT with the Myo-
suit was shorter than at baseline (training 1, see Fig. 3). 
All three participants were able to cover a longer distance 
with the Myosuit than at baseline from training session 2 
onwards.
Heart rate and perceived exertion
The participants’ heart rates presented with a large var-
iability over a range of 66 bpm to 121 bpm at the end of 
10MWTs (see Additional file 1: Figure S1) and 89 bpm 
to 141  bpm at the end of 2minWTs. The perceived 


































































Fig. 2. 10MWT walking speed measured in trainings 1 to 4 with 
Myosuit assistance, relative to baseline 10MWT speed measured 
without the Myosuit in training 0. During the training blocks, the 
participants completed an individualized program comprising 
walking, balance and strength exercises. 10MWTs were performed 
at the beginning and end of training session, except for P6, P7 and 
P8, where only one 10MWT was performed at the beginning of 
the session and a 2minWT in place of the second 10MWT towards 
the end of the session (see also Fig. 3). Data points and baseline are 
calculated as the mean of the two 10MWTs during the respective 


























































































Baseline 2minWT without Myosuit
Fig. 3 Distance covered in 2minWT during trainings 1 to 4 with 
Myosuit assistance, relative to baseline 2minWT distance measured 
without the Myosuit in training 0. Instead of the second 10MWT 
in training sessions 1 to 4, the last three participants performed a 
2minWT during each training session
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ranged from 6 to 16 after both 10MWTs (see Addi-
tional file 1: Figure S2) and 2minWTs.
Discussion
Training with the Myosuit is feasible
Individuals with diverse neurological and 
neuromuscular motor disorders and substantially 
different baseline walking capacity (range in walking 
speed of 0.18 to 1.7  m/s, see Table  2) successfully 
engaged in Myosuit-assisted training  (see Additional 
file 2).
Eight out of 12 enrolled participants reached 
the study endpoint. This retention rate is slightly 
higher than the ones found in previous studies 
with community-residing participants and rigid 
exoskeletons, where only 54% [15] and 50% [17] of 
the participants completed the entire protocol. These 
previous studies included more sessions and targeted 
more severely affected populations than our work. In 
a study with a more lightweight exoskeleton for partial 
movement assistance of the knee, 80% of participants 
completed the protocol [27].
Three out of the four participants who did not 
reach the current study’s endpoint withdrew or were 
excluded due to reasons unrelated to the study, e.g. time 
constraints or unrelated medical events. We speculate 
that this relatively high proportion of study-unrelated 
drop-outs can at least in parts be attributed to the 
present outpatient setting. The habitual environment of 
individuals could be an important factor for access and 
adherence, evidenced further in the fact that even very 
complex multi-visit studies with inpatient participants 
reported complete participant retention [16, 18]. We 
expect that future studies in which the Myosuit is used 
in inpatient settings might also show higher participant 
retention.
The current, relatively high retention rate is indicative 
of a good participant tolerance towards Myosuit-assisted 
training. It might further indicate that the participants’ 
expectations were met when training with the Myosuit, 
as also evidenced in the predominantly positive self-
reported effects of Myosuit training. The unstructured 
format of our post-training interviews did not allow 
for a systematic analysis of these effects, though. In 
addition, our recruitment strategy of using referral from 
clinicians and word of mouth might have resulted in a 
study population with a favorably biased attitude towards 
robot-assisted training. Prospective participants willingly 
invested time and effort to travel to the study site and 
participate in at least the initial training session, likely 
because they expected to benefit from the Myosuit or 
were curious to test it.
Training with the Myosuit is safe
No adverse events or adverse effects were reported 
during or after the more than 40 training sessions in 
which a variety of training exercises were performed 
(see “Exercise modules”). This shows that the protocol 
and exercise programs used in this study were safe, and 
that the Myosuit was well-tolerated by the diverse study 
population.
The only participant that withdrew from the study 
for study-related reasons, an individual with limb-
girdle muscle dystrophy (see Table  2), reported feeling 
unsafe with the Myosuit. We attribute this feeling to an 
incompatibility between the participant’s pronounced 
compensatory strategy and the Myosuit assistance during 
walking that resulted in an undesirable trunk rotation 
during stance phase. Since this participant reported a 
history of falls, psychological factors might have added to 
the feeling of insecurity when walking with the Myosuit. 
This observation suggests that the perceived safety and 
feasibility of Myosuit training might decrease with an 
increasing departure from unimpaired gait kinematics.
The moderate DOMS reported by five participants 
might be attributed to elevated training intensity, and as 
such, could be desirable within reasonable limits.
Individuals need time to adapt to the Myosuit
Due to the limited number of cases in our study, we 
interpret the positive trend observed in 10MWT and 
2minWT performance primarily as additional evidence 
towards the safety and tolerance of Myosuit training, 
and not with regard to the clinical meaningfulness 
of improvements. In addition, a more individual 
interpretation of the assistive effects of the Myosuit is 
also limited by the lack of detailed muscle strength and 
sensory scores for our study participants (except P3 and 
P4, see Additional file 1: Figures S3 and S4).
The observed increase in 10MWT and 2minWT 
performance might originate from a motor adaptation 
process. In unpublished results from a concurrent study, 
we have seen that unimpaired participants needed a 
period of approximately 10  min of continuous walking 
to adapt to the assistance from the Myosuit. Similarly, 
participants in the present study could have perceived 
the Myosuit’s assistance as a disturbance initially as 
they lacked an internal model of assisted walking [38]. 
Previous research showed that the ability of stroke 
survivors to form such internal models is impaired 
[39], suggesting that individuals with a motor disorder 
might need a longer adaptation period than unimpaired 
individuals. One can speculate that for example the 
pronounced increase in 10MWT walking speed of 
participant P3 is at least in parts explained by an ongoing 
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motor adaptation and familiarization process. This is also 
because the well-preserved leg muscle strength of P3 (hip 
extension muscle function grade 4 (left) and 5 (right), 
bilateral knee extension grade 5, see Additional file  1: 
Figure S3) would in principal not suggest P3 as prime 
candidate to benefit from Myosuit assistance.
Based on our findings, an initial decrease in 
performance for the first 90  min of exposure time (e.g. 
2 training session a 45  min) might have to be expected 
for most users. An open area of research is the design of 
familiarization protocols that minimize the time required 
to adapt to the Myosuit’s assistance.
Two out of the three individuals whose 10MWT 
speed with the Myosuit was persistently slower than 
at baseline, P1 and P6, reported to not use any walking 
aids in everyday life, and presented with baseline walking 
speeds of more than 1 m/s. Thus, P1 and P6 likely did not 
require—and hence, might not have been able to profit 
from—robotic gait assistance, similar to unimpaired 
individuals. Hence, the habitual use of walking aids could 
be an effective additional criterion to identify individuals 
who potentially profit from Myosuit assistance. Their 
reduced performance might in parts be related to 
the moderate added weight by the Myosuit of 5.5  kg. 
Alternatively, the level of Myosuit assistance might have 
been chosen too high for these more capable individuals 
during the tuning heuristic used in this study (see 
Additional file  1). This would underline the persistent 
need for automated, non-subjective algorithms to adjust 
and personalize assistance for diverse users.
Age and activity might confound training efficacy
Two independent simple linear regression analy-
ses between our supporting outcome metrics and the 
observed change in 10MWT walking speed indicate a 
moderately positive correlation with mean daily step 
count (t(6) = 2.2, p = 0.07,  R2 = 0.44, see Fig.  4a) and a 
moderately negative correlation with age (t(6) = -2.1, 
p = 0.08,  R2 = 0.43, Fig. 4b). While these potential corre-
lations seem reasonable—more active and younger indi-
viduals might achieve a larger improvement in 10MWT 
walking speed—, the limited size of our study population 
and resulting lack of statistical evidence mandate caution 
during further interpretation. In particular participant 
P3 stands out in terms of age, daily step count, and the 
observed change in 10MWT walking speed, and thereby 
substantially affects the regression results. Future con-
trolled trials should consider matching age and the habit-
ual activity level between study groups.
Next steps to assess training efficacy
Building on the results from this study, the next step is to 
evaluate the efficacy of Myosuit-assisted exercise training 
compared to conventional exercise training. Future 
work should clarify to what extent the observed positive 
trend in walking performance originates from motor 
adaptation to the Myosuit, constitutes an improvement 
of intrinsic motor performance, or is a psychologically-
driven placebo effect. Further, additional assessments like 
the Berg Balance Score will help us analyze the effects 
of Myosuit training beyond walking function. Such 
quantitative assessments should be supported by patient-
reported outcome measures through a more systematic 
use of questionnaires. A cross-over study design, as for 
example in [27], might help to efficiently analyze the 
available participant population.
Conclusions
Activity-based training with the Myosuit is safe, 
feasible and well-tolerated by individuals with diverse 
neurological and neuromuscular motor disorders.
This first clinical test with the Myosuit provides 
evidence that a larger, randomized controlled trial with 
one Myosuit-assisted and one conventional training 
arm would be feasible, even when including a diverse 
population. Our study results also suggest a positive 
effect on walking speed and endurance in basically 
ambulatory subjects when supported by the Myosuit.
Supplementary information
Supplementary information accompanies this paper at https ://doi.
org/10.1186/s1298 4-020-00765 -4.
Additional file 1: Figure S1. Mean Heart Rate after completion of 
10MWTs across training session 1 to 4. The mean heart rate is calculated 
as the mean of the heart rates after the two 10MWTs in each session, 
Fig. 4 a Mean daily step count was moderately positively correlated 
with the observed change in 10MWT walking speed. The number 
of daily steps was recorded with a wrist-worn step counter during 
daily activities between training sessions. b The participants’ age 
was moderately negatively correlated with the observed change 
in 10MWT walking speed. P3 (green triangle) showed the largest 
increase in 10MWT speed, was the most active during daily life, and 
the youngest of all participants
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except for P6, P7 and P8, where only one 10MWT was performed. Figure 
S2. Mean Borg Scale Rating of 10MWTs across training session 1 to 4. The 
mean rating is calculated as the mean of the ratings of the two 10MWTs 
in each session, except for P6, P7 and P8, where only one 10MWT was 
performed. Figure S3. Detailed key muscle strength and sensory scores 
(light touch and pin prick) for participant P3. The form has been repro-
duced by the authors without any personal information to safeguard the 
participants privacy. Figure S4. Detailed key muscle strength and sensory 
scores (light touch and pin prick) for participant P4. The form has been 
reproduced by the authors without any personal information to safeguard 
the participants privacy.
Additional file 2. Video file presenting exemplary exercises and 
assessments (10MWT and 2minWT) during activity-based training with 
the Myosuit.
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